Instil Bio TIL Income Statement (2020-2026)

NASDAQ TIL
$7.43 +0.04 (+0.54%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
6.44M5.30M6.46M6.48M6.49M6.50M6.50M6.50M6.50M6.50M6.50M6.50M6.53M6.53M6.56M6.75M6.78M6.78M6.78M6.78M
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)
29.06M42.58M39.17M41.50M39.66M20.72M20.67M8.46M8.49M1.98M7.26M2.92M0.56M1.10M5.37M6.74M9.13M3.50M0.67M0.27M
Selling, General & Administrative (Quarter)
13.96M11.18M15.11M17.22M16.99M12.91M13.22M11.52M11.94M10.87M12.42M10.71M10.71M10.37M9.11M6.16M5.89M6.06M5.35M5.13M
Restructuring Costs (Quarter)
23.17M24.55M1.01M46.28M0.17M4.28M0.51M2.36M0.35M16.08M0.54M0.99M0.18M
Other Operating Expenses (Quarter)
10.00M10.00M1.62M
Operating Expenses (Quarter)
43.02M53.75M54.29M58.72M56.65M56.80M58.45M20.99M66.72M13.02M23.95M14.13M23.63M11.82M30.56M23.44M15.02M9.56M7.01M5.58M
Operating Income (Quarter)
-43.02M-53.75M-54.29M-58.72M-56.65M-56.80M-58.45M-20.99M-66.72M-13.02M-23.95M-14.13M-23.63M-11.82M-30.56M-23.44M-15.02M-9.56M-7.01M-5.58M
EBIT (Quarter)
-43.02M-53.75M-54.29M-58.72M-56.65M-56.80M-58.45M-20.99M-66.72M-13.02M-23.95M-14.13M-23.63M-11.82M-30.56M-23.44M-15.02M-9.56M-7.01M-5.58M
Non-operating items
Interest & Investment Income (Quarter)
0.02M0.04M0.10M0.49M1.28M1.80M2.07M2.29M2.31M2.19M2.06M1.92M1.65M1.35M1.18M1.04M0.89M0.75M0.68M0.63M
Other Non Operating Income (Quarter)
0.04M-0.18M-0.01M
Non Operating Income (Quarter)
-0.66M-0.57M-0.42M-1.03M-0.41M1.30M-0.06M0.63M-1.03M-0.12M-0.43M-0.70M-0.53M-1.20M0.04M0.34M-0.12M-0.06M
Net income details
EBT (Quarter)
-43.66M-54.29M-54.60M-59.60M-56.59M-54.45M-57.07M-18.66M-67.43M-12.93M-23.87M-14.21M-23.98M-13.47M-30.48M-23.98M-15.71M-10.38M-7.88M-7.60M
Tax Provisions (Quarter)
-0.66M1.06M-0.49M-0.61M-0.37M-0.60M
Profit After Tax (Quarter)
-43.01M-55.33M-54.12M-58.99M-56.22M-54.25M-57.07M-18.66M-67.16M-12.78M-24.30M-14.92M-22.91M-11.72M-28.42M-21.39M-13.39M-8.19M-4.15M-4.35M
Income from Non-Controlling Interests (Quarter)
-0.02M-0.03M-0.32M-0.34M-0.17M0.41M0.32M-0.18M0.04M0.40M-0.26M-0.06M0.40M-0.13M-0.06M-0.04M0.07M0.02M-0.08M-0.04M
Income from Continuing Operations (Quarter)
-43.01M-55.35M-54.12M-58.99M-56.22M-53.84M-57.07M-18.66M-67.43M-12.93M-23.87M-14.21M-23.98M-13.47M-30.48M-23.98M-15.71M-10.38M-7.88M-7.60M
Consolidated Net Income (Quarter)
-43.01M-55.35M-54.12M-58.99M-56.22M-53.84M-57.07M-18.66M-67.43M-12.93M-23.87M-14.21M-23.98M-13.47M-30.48M-23.98M-15.71M-10.38M-7.88M-7.60M
Income towards Parent Company (Quarter)
-43.01M-55.35M-54.12M-58.99M-56.22M-53.84M-57.07M-18.66M-67.43M-12.93M-23.87M-14.21M-23.98M-13.47M-30.48M-23.98M-15.71M-10.38M-7.88M-7.60M
Net Income towards Common Stockholders (Quarter)
-43.01M-55.35M-54.12M-58.99M-56.22M-53.84M-57.07M-18.66M-67.43M-12.93M-23.87M-14.21M-23.98M-13.47M-30.48M-23.98M-15.71M-10.38M-7.88M-7.60M
Additional items
EPS (Basic) (Quarter)
-6.68-10.44-8.38-9.12-8.67-8.31-8.77-2.87-10.37-1.99-3.67-2.19-3.69-2.07-4.67-3.63-2.32-1.56-1.16-1.12
EPS (Diluted) (Quarter)
-6.68-10.44-8.38-9.12-8.67-8.31-8.77-2.87-10.37-1.99-3.67-2.19-3.69-2.07-4.67-3.63-2.32-1.56-1.16-1.12
Shares Outstanding (Quarter)
6.44M5.30M6.46M6.47M6.48M6.48M6.50M6.50M6.50M6.50M6.50M6.50M6.51M6.51M6.53M6.60M6.76M6.67M6.78M6.78M
Shares Outstanding (Diluted) (Quarter)
6.44M5.30M6.46M6.47M6.48M6.48M6.50M6.50M6.50M6.50M6.50M6.50M6.51M6.51M6.53M6.60M6.76M6.67M6.78M6.78M
EBITDA (Quarter)
-43.02M-53.75M-54.29M-58.72M-56.65M-56.80M-58.45M-20.99M-66.72M-13.02M-23.95M-14.13M-23.63M-11.82M-30.56M-23.44M-15.02M-9.56M-7.01M-5.58M
Interest Expenses (Quarter)
0.33M0.81M2.12M0.88M0.59M2.00M3.41M1.98M2.00M2.01M3.00M1.10M1.58M1.58M1.57M1.55M2.65M
Tax Rate (Quarter)
1.51-1.950.891.020.661.11